{"id":"https://openalex.org/W4366997625","doi":"https://doi.org/10.2337/figshare.22266355","title":"The Broader Economic Value of Treatment for Diabetic Macular Edema","display_name":"The Broader Economic Value of Treatment for Diabetic Macular Edema","publication_year":2023,"publication_date":"2023-04-26","ids":{"openalex":"https://openalex.org/W4366997625","doi":"https://doi.org/10.2337/figshare.22266355"},"language":"en","primary_location":{"id":"doi:10.2337/figshare.22266355","doi":"https://doi.org/10.2337/figshare.22266355","is_oa":true,"landing_page_url":"https://doi.org/10.2337/figshare.22266355","pdf_url":"https://diabetesjournals.figshare.com/articles/figure/The_Broader_Economic_Value_of_Treatment_for_Diabetic_Macular_Edema/22266355/1/files/39583390.pdf","source":null,"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Diabetes Association","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://diabetesjournals.figshare.com/articles/figure/The_Broader_Economic_Value_of_Treatment_for_Diabetic_Macular_Edema/22266355/1/files/39583390.pdf","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052043502","display_name":"Karen Mulligan","orcid":"https://orcid.org/0000-0002-6071-5564","observed_orcids":["https://orcid.org/0000-0002-6071-5564"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Karen Mulligan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100772901","display_name":"Jae\u2010Hong Kim","orcid":"https://orcid.org/0000-0002-8019-0208","observed_orcids":["https://orcid.org/0000-0002-8019-0208"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jaehong Kim","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086722669","display_name":"Bryan Tysinger","orcid":"https://orcid.org/0000-0002-8497-3664","observed_orcids":["https://orcid.org/0000-0002-8497-3664"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bryan Tysinger","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008042781","display_name":"Jill F. Blim","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jill Blim","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091416305","display_name":"Geoffrey G. Emerson","orcid":"https://orcid.org/0000-0003-0520-7046","observed_orcids":["https://orcid.org/0000-0003-0520-7046"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Geoffrey Emerson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001994846","display_name":"Philip J. Ferrone","orcid":"https://orcid.org/0000-0003-1748-4614","observed_orcids":["https://orcid.org/0000-0003-1748-4614"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Philip J. Ferrone","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090646410","display_name":"Judy E. Kim","orcid":"https://orcid.org/0000-0001-8695-4363","observed_orcids":["https://orcid.org/0000-0001-8695-4363"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Judy E. Kim","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011663361","display_name":"Seth A. Seabury","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Seth Seabury","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"Paul Hahn","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul Hahn","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.8676999807357788,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.8676999807357788,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.1251000016927719,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10841","display_name":"Economic and Environmental Valuation","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/diabetic-macular-edema","display_name":"diabetic macular edema","score":1.0},{"id":"https://openalex.org/keywords/anti-vegf-therapy","display_name":"anti-VEGF therapy","score":0.7960000038146973},{"id":"https://openalex.org/keywords/laser-photocoagulation","display_name":"laser photocoagulation","score":0.8619999885559082},{"id":"https://openalex.org/keywords/intravitreal-steroids","display_name":"intravitreal steroids","score":0.7850000262260437},{"id":"https://openalex.org/keywords/quality-adjusted-life-years","display_name":"quality-adjusted life years","score":0.9660000205039978},{"id":"https://openalex.org/keywords/life-expectancy","display_name":"life expectancy","score":0.8429999947547913},{"id":"https://openalex.org/keywords/lifetime-earnings","display_name":"lifetime earnings","score":0.7279999852180481},{"id":"https://openalex.org/keywords/disability","display_name":"disability","score":0.5789999961853027},{"id":"https://openalex.org/keywords/employment","display_name":"employment","score":0.414000004529953},{"id":"https://openalex.org/keywords/cost-benefit-analysis","display_name":"cost-benefit analysis","score":0.6840000152587891},{"id":"https://openalex.org/keywords/microsimulation-model","display_name":"microsimulation model","score":0.7699999809265137}],"concepts":[{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.6258068680763245},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5959774255752563},{"id":"https://openalex.org/C2985127711","wikidata":"https://www.wikidata.org/wiki/Q631361","display_name":"Diabetic macular edema","level":4,"score":0.5586002469062805},{"id":"https://openalex.org/C2781426361","wikidata":"https://www.wikidata.org/wiki/Q5326940","display_name":"Earnings","level":2,"score":0.5092538595199585},{"id":"https://openalex.org/C133925201","wikidata":"https://www.wikidata.org/wiki/Q188419","display_name":"Life expectancy","level":3,"score":0.4639410972595215},{"id":"https://openalex.org/C149923435","wikidata":"https://www.wikidata.org/wiki/Q37732","display_name":"Demography","level":1,"score":0.3884562849998474},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32143130898475647},{"id":"https://openalex.org/C2779829184","wikidata":"https://www.wikidata.org/wiki/Q631361","display_name":"Diabetic retinopathy","level":3,"score":0.2948213219642639},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.23043406009674072},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.18562954664230347},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.1693200170993805},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.13958996534347534},{"id":"https://openalex.org/C10138342","wikidata":"https://www.wikidata.org/wiki/Q43015","display_name":"Finance","level":1,"score":0.11319577693939209},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.09962841868400574},{"id":"https://openalex.org/C144024400","wikidata":"https://www.wikidata.org/wiki/Q21201","display_name":"Sociology","level":0,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.2337/figshare.22266355","doi":"https://doi.org/10.2337/figshare.22266355","is_oa":true,"landing_page_url":"https://doi.org/10.2337/figshare.22266355","pdf_url":"https://diabetesjournals.figshare.com/articles/figure/The_Broader_Economic_Value_of_Treatment_for_Diabetic_Macular_Edema/22266355/1/files/39583390.pdf","source":null,"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Diabetes Association","raw_type":"posted-content"},{"id":"doi:10.2337/figshare.22266355.v1","doi":"https://doi.org/10.2337/figshare.22266355.v1","is_oa":true,"landing_page_url":"https://doi.org/10.2337/figshare.22266355.v1","pdf_url":null,"source":null,"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Diabetes Association","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.2337/figshare.22266355","doi":"https://doi.org/10.2337/figshare.22266355","is_oa":true,"landing_page_url":"https://doi.org/10.2337/figshare.22266355","pdf_url":"https://diabetesjournals.figshare.com/articles/figure/The_Broader_Economic_Value_of_Treatment_for_Diabetic_Macular_Edema/22266355/1/files/39583390.pdf","source":null,"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Diabetes Association","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4366997625.pdf","grobid_xml":"https://content.openalex.org/works/W4366997625.grobid-xml"},"referenced_works_count":3,"referenced_works":["https://openalex.org/W1535801756","https://openalex.org/W2075206985","https://openalex.org/W2092553550"],"related_works":["https://openalex.org/W2107826392","https://openalex.org/W2053282839","https://openalex.org/W1975886575","https://openalex.org/W2078434988","https://openalex.org/W4398156667","https://openalex.org/W2045239704","https://openalex.org/W4400897194","https://openalex.org/W4286470941","https://openalex.org/W7097232998","https://openalex.org/W2274080969"],"abstract_inverted_index":{"Objective:":[0],"To":[1,80],"simulate":[2,48],"economic":[3,15,53,227],"outcomes":[4,54],"for":[5,40,55,70,129,224],"individuals":[6,56],"with":[7,23,57,136,143,182],"diabetic":[8],"macular":[9],"edema":[10],"(DME)":[11],"and":[12,19,31,52,68,78,87,139,159,178,201,231,238,242,247],"estimate":[13],"the":[14,36,82,93,112,185],"value":[16,37,209,228],"of":[17,38,85,89,213,240],"direct":[18,193],"indirect":[20,203],"benefits":[21,88,166],"associated":[22],"DME":[24,90,130,187,225],"treatment.":[25],"Methods:":[26],"Our":[27],"study":[28],"pairs":[29],"individual":[30,152],"cohort":[32,188],"analyses":[33],"to":[34,47,118,147,219,229],"demonstrate":[35],"treatment":[39,91,104,168,214],"DME.":[41,58],"We":[42],"used":[43,96],"a":[44,71,97],"microsimulation":[45],"model":[46],"self-reported":[49],"vision":[50],"(SRV)":[51],"Four":[59],"scenarios":[60],"derived":[61,106],"from":[62,107,167,216],"clinical":[63],"trial":[64],"data":[65],"were":[66],"simulated":[67],"compared":[69],"lifetime":[72,176],"horizon:":[73],"untreated,":[74],"anti-VEGF":[75],"therapy,":[76],"laser,":[77],"steroid.":[79],"quantify":[81],"relative":[83,146],"magnitude":[84],"costs":[86],"in":[92],"U.S.,":[94],"we":[95],"cohort-level":[98],"analysis":[99],"based":[100],"on":[101],"real":[102],"world":[103],"parameters":[105],"published":[108],"data.":[109],"Results:":[110],"In":[111],"model,":[113],"excellent/good":[114,137],"SRV":[115,138,145],"roughly":[116],"corresponded":[117],"20/40":[119],"or":[120],"better":[121],"visual":[122],"acuity.":[123],"A":[124,150],"representative":[125],"51-year":[126],"old":[127],"treated":[128,151],"would":[131,153],"spend":[132],"30-35%":[133],"additional":[134],"years":[135,142,172,181],"29-32%":[140],"fewer":[141,180],"fair/poor":[144],"being":[148],"untreated.":[149],"experience":[154],"4-5%":[155],"greater":[156,175],"life":[157,163,236,241],"expectancy":[158],"9-13%":[160],"more":[161,171],"quality-adjusted":[162],"years.":[164],"Indirect":[165],"included":[169],"6-9%":[170],"working,":[173],"12-19%":[174],"earnings,":[177],"8-16%":[179],"disability.":[183],"For":[184],"U.S.":[186],"(1.1.":[189],"million":[190],"people),":[191],"total":[192,202],"benefit":[194,204],"was":[195,205],"$63.0":[196],"billion":[197,218],"over":[198],"20":[199],"years,":[200],"$4.8":[206],"billion.":[207,221],"Net":[208],"(benefit":[210],"minus":[211],"cost)":[212],"ranged":[215],"$28.1":[217],"$52.8":[220],"Conclusions:":[222],"Treatment":[223],"provides":[226],"patients":[230],"society":[232],"through":[233,244],"improved":[234,245],"vision,":[235],"expectancy,":[237],"quality":[239],"indirectly":[243],"employment":[246],"disability":[248],"outcomes.":[249]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-27T00:00:00"}